Tara Bancroft
Stock Analyst at TD Cowen
(4.87)
# 343
Out of 4,676 analysts
293
Total ratings
55.7%
Success rate
31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGNX MacroGenics | Maintained: Hold | n/a | $4.22 | - | 15 | Aug 17, 2026 | |
| CELC Celcuity | Maintained: Buy | n/a | $92.00 | - | 14 | Aug 17, 2026 | |
| FATE Fate Therapeutics | Maintained: Hold | n/a | $2.57 | - | 14 | Aug 17, 2026 | |
| STRO Sutro Biopharma | Maintained: Buy | n/a | $20.48 | - | 13 | Aug 12, 2026 | |
| TCRX TScan Therapeutics | Maintained: Buy | n/a | $0.7788 | - | 12 | Aug 12, 2026 | |
| VALN Valneva SE | Initiated Coverage: Buy | $12 | $7.13 | +68.30% | 1 | Aug 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Maintained: Hold | n/a | $3.47 | - | 3 | Aug 10, 2026 | |
| WHWK Whitehawk Therapeutics | Maintained: Hold | n/a | $4.46 | - | 13 | Aug 6, 2026 | |
| GERN Geron | Rated: Buy | $3 | $1.47 | +104.08% | 20 | Aug 5, 2026 | |
| EYPT EyePoint | Maintained: Buy | $20 | $14.75 | +35.59% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $23.34 | - | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $155 | $155.10 | -0.06% | 17 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $60 | $48.22 | +24.43% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $58.07 | +29.15% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $48.74 | +53.88% | 14 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $110 → $103 | $100.95 | +1.54% | 21 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $10.04 | +99.20% | 24 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.90 | - | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $78.84 | - | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $4.08 | - | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.64 | - | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $38.31 | - | 3 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20.00 | $16.73 | +19.55% | 16 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.59 | n/a | 2 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.84 | n/a | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.14 | n/a | 2 | Jul 26, 2024 |
MacroGenics
Aug 17, 2026
Maintained: Hold
Price Target: n/a
Current: $4.22
Upside: -
Celcuity
Aug 17, 2026
Maintained: Buy
Price Target: n/a
Current: $92.00
Upside: -
Fate Therapeutics
Aug 17, 2026
Maintained: Hold
Price Target: n/a
Current: $2.57
Upside: -
Sutro Biopharma
Aug 12, 2026
Maintained: Buy
Price Target: n/a
Current: $20.48
Upside: -
TScan Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: n/a
Current: $0.7788
Upside: -
Valneva SE
Aug 11, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $7.13
Upside: +68.30%
Rocket Pharmaceuticals
Aug 10, 2026
Maintained: Hold
Price Target: n/a
Current: $3.47
Upside: -
Whitehawk Therapeutics
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $4.46
Upside: -
Geron
Aug 5, 2026
Rated: Buy
Price Target: $3
Current: $1.47
Upside: +104.08%
EyePoint
Aug 5, 2026
Maintained: Buy
Price Target: $20
Current: $14.75
Upside: +35.59%
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $23.34
Upside: -
Aug 5, 2026
Maintained: Buy
Price Target: $155
Current: $155.10
Upside: -0.06%
Aug 5, 2026
Rated: Buy
Price Target: $50 → $60
Current: $48.22
Upside: +24.43%
Aug 5, 2026
Maintained: Buy
Price Target: $75
Current: $58.07
Upside: +29.15%
Aug 3, 2026
Maintained: Buy
Price Target: $75
Current: $48.74
Upside: +53.88%
Aug 3, 2026
Downgraded: Hold
Price Target: $110 → $103
Current: $100.95
Upside: +1.54%
Aug 3, 2026
Maintained: Buy
Price Target: $20
Current: $10.04
Upside: +99.20%
Jul 30, 2026
Maintained: Buy
Price Target: n/a
Current: $3.90
Upside: -
Jul 30, 2026
Maintained: Buy
Price Target: n/a
Current: $78.84
Upside: -
Jun 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $4.08
Upside: -
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $25.64
Upside: -
Apr 1, 2026
Maintained: Buy
Price Target: n/a
Current: $38.31
Upside: -
Feb 19, 2026
Maintained: Buy
Price Target: $20.00
Current: $16.73
Upside: +19.55%
Mar 14, 2025
Rated: Hold
Price Target: n/a
Current: $1.59
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: n/a
Current: $5.84
Upside: n/a
Jul 26, 2024
Downgraded: Hold
Price Target: n/a
Current: $17.14
Upside: n/a